NICE guidance on pazopanib for first-line treatment of advanced renal-cell carcinoma.

The lancet oncology

Volumn 12, Issue 3, 2011, Pages 221-222

  Griffiths, Christian ^a   Hay, Nicola ^a   Sutcliffe, Frances ^a   Stevens, Andrew ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PAZOPANIB; PYRIMIDINE DERIVATIVE; SULFONAMIDE;

HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; NOTE; PATHOLOGY;

ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; HUMANS; KIDNEY NEOPLASMS; PYRIMIDINES; SULFONAMIDES;

MLCS; MLOWN;

EID: 79959796486     PISSN: None     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/s1470-2045(11)70042-0     Document Type: Note

References (0)